The potential of the CSCs population in ovarian cancer cells is defined by cell markers, including ALDH enzymatic activity and the stem cell marker CD133 [16,17], suggesting the potential role of ALDH+/CD133+ cells as the ovarian cancer cells of origin [18]. The gene discussed is PROM1; the disease is ovarian carcinoma.